JP2025016453A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2025016453A5 JP2025016453A5 JP2024169863A JP2024169863A JP2025016453A5 JP 2025016453 A5 JP2025016453 A5 JP 2025016453A5 JP 2024169863 A JP2024169863 A JP 2024169863A JP 2024169863 A JP2024169863 A JP 2024169863A JP 2025016453 A5 JP2025016453 A5 JP 2025016453A5
- Authority
- JP
- Japan
- Prior art keywords
- collagenase
- formulation
- μbar
- lyophilized
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962788916P | 2019-01-06 | 2019-01-06 | |
| US62/788,916 | 2019-01-06 | ||
| PCT/US2020/012202 WO2020142701A1 (en) | 2019-01-06 | 2020-01-03 | Collagenase formulations and methods of producing the same |
| JP2021539410A JP7565280B2 (ja) | 2019-01-06 | 2020-01-03 | コラゲナーゼ製剤およびその製造方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539410A Division JP7565280B2 (ja) | 2019-01-06 | 2020-01-03 | コラゲナーゼ製剤およびその製造方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026070889A Division JP2026133415A (ja) | 2019-01-06 | 2026-04-22 | コラゲナーゼ製剤およびその製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025016453A JP2025016453A (ja) | 2025-02-04 |
| JP2025016453A5 true JP2025016453A5 (cg-RX-API-DMAC10.html) | 2025-04-25 |
| JP7855655B2 JP7855655B2 (ja) | 2026-05-08 |
Family
ID=69845512
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539410A Active JP7565280B2 (ja) | 2019-01-06 | 2020-01-03 | コラゲナーゼ製剤およびその製造方法 |
| JP2024169863A Active JP7855655B2 (ja) | 2019-01-06 | 2024-09-30 | コラゲナーゼ製剤およびその製造方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539410A Active JP7565280B2 (ja) | 2019-01-06 | 2020-01-03 | コラゲナーゼ製剤およびその製造方法 |
Country Status (10)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113025599B (zh) * | 2021-04-02 | 2023-09-12 | 重庆科润生物医药研发有限公司 | 一种重组溶组织梭菌i型胶原酶及其制备方法和应用 |
| CN112941058B (zh) * | 2021-04-02 | 2023-12-05 | 重庆科润生物医药研发有限公司 | 一种重组溶组织梭菌ii型胶原酶及其制备方法和应用 |
| CN114264633B (zh) * | 2022-02-10 | 2022-09-06 | 上海蓝长科技集团有限公司 | 一种福尔马肼聚合物冻干粉及制备方法 |
| CN118829726A (zh) * | 2022-03-08 | 2024-10-22 | 科纳斯特股份有限公司 | 包含胶原酶、钙、组氨酸及甘氨酸的组合物及胶原酶的稳定化方法 |
| WO2026094005A1 (en) * | 2024-11-04 | 2026-05-07 | Endo Biologics Limited | Compositions comprising collagenase for use in treatment of plantar fasciitis |
| CN119656117B (zh) * | 2024-12-18 | 2025-08-29 | 远大生命科学(鞍山)有限公司 | 一种药物组合物及其制备方法和用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1820516B1 (en) | 1999-02-22 | 2013-07-24 | University of Connecticut | Novel albumin-free factor VIII formulations |
| US6440414B1 (en) | 1999-10-01 | 2002-08-27 | Amgen Inc. | Pharmaceutical compositions of fibrinolytic agent |
| US20070224184A1 (en) * | 2006-02-22 | 2007-09-27 | The Research Foundation Of The State University Of New York | Method for treating cellulite |
| KR20080071192A (ko) * | 2005-11-22 | 2008-08-01 | 와이어쓰 | 면역글로불린 융합 단백질 제형 |
| US7811560B2 (en) | 2006-01-30 | 2010-10-12 | Auxilium Us Holdings, Llc | Compositions and methods for treating collagen-mediated diseases |
| EP2130551B1 (en) * | 2008-06-02 | 2012-06-06 | Roche Diagnostics GmbH | Improved purification of collagenases from clostridium histolyticum liquid culture |
| US10119131B2 (en) | 2011-03-16 | 2018-11-06 | Biospecifics Technologies Corp. | Compositions and methods for producing clostridial collagenases |
| JP2014530873A (ja) * | 2011-10-21 | 2014-11-20 | オーキシリウム インターナショナル ホールディングス，インコーポレイテッド | Ｅｆｐの治療または低減方法 |
| EP4772625A2 (en) | 2012-01-12 | 2026-07-08 | Endo Biologics Limited | Clostridium histolyticum enzyme |
| WO2014144859A1 (en) | 2013-03-15 | 2014-09-18 | Biospecifics Technologies Corporation | Treatment method and product for uterine fibroids using purified collagenase |
| US10137179B2 (en) * | 2016-05-18 | 2018-11-27 | Hyalo Technologies, LLC | Composition and method of preparation of protease microparticulate slow release preparation |
| CN110022855B (zh) * | 2016-10-07 | 2024-07-16 | 瑞泽恩制药公司 | 室温稳定的冻干蛋白质 |
| DK3589204T3 (da) * | 2017-03-01 | 2025-06-30 | Endo Operations Ltd | Apparat og fremgangsmåde til vurdering og behandling af cellulitis |
-
2020
- 2020-01-03 MX MX2021008017A patent/MX2021008017A/es unknown
- 2020-01-03 WO PCT/US2020/012202 patent/WO2020142701A1/en not_active Ceased
- 2020-01-03 AU AU2020204922A patent/AU2020204922B2/en active Active
- 2020-01-03 BR BR112021012675-9A patent/BR112021012675A2/pt active Search and Examination
- 2020-01-03 IL IL321891A patent/IL321891A/en unknown
- 2020-01-03 KR KR1020217024557A patent/KR20210113271A/ko not_active Ceased
- 2020-01-03 JP JP2021539410A patent/JP7565280B2/ja active Active
- 2020-01-03 US US17/419,899 patent/US20220305094A1/en not_active Abandoned
- 2020-01-03 KR KR1020267010947A patent/KR20260051486A/ko active Pending
- 2020-01-03 EP EP20712071.8A patent/EP3906014A1/en active Pending
- 2020-01-03 CN CN202080010875.3A patent/CN113382714A/zh active Pending
- 2020-01-03 IL IL284270A patent/IL284270B2/en unknown
-
2023
- 2023-09-29 US US18/478,368 patent/US12303557B2/en active Active
-
2024
- 2024-09-30 JP JP2024169863A patent/JP7855655B2/ja active Active
-
2025
- 2025-04-22 US US19/185,838 patent/US20250249080A1/en active Pending
- 2025-06-30 AU AU2025204915A patent/AU2025204915A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Thakral et al. | Stabilizers and their interaction with formulation components in frozen and freeze-dried protein formulations | |
| AU2018203556B2 (en) | Recombinant clostridium botulinum neurotoxins | |
| KR101744900B1 (ko) | 보툴리눔 독소를 포함하는 안정한 액상 조성물 | |
| WO2010146598A2 (en) | Stable, dried rotavirus vaccine, compositions and process for preparation thereof | |
| JP2021521159A5 (cg-RX-API-DMAC10.html) | ||
| JP2003510369A (ja) | フィブリン溶解剤の薬剤組成物 | |
| JP2023539476A5 (cg-RX-API-DMAC10.html) | ||
| CA2554018A1 (en) | Lyophilization method to improve excipient crystallization | |
| CN105985942A (zh) | 赖氨酰肽链内切酶冻干及贮存保护剂 | |
| CN114317700B (zh) | 荧光pcr试剂冻干保护剂、冻干方法及应用 | |
| CN114752703A (zh) | 一种新型冠状病毒核酸的冻干型检测试剂及其制备方法 | |
| JP2023538669A5 (cg-RX-API-DMAC10.html) | ||
| US7101693B2 (en) | Plasticized hydrophilic glasses for improved stabilization of biological agents | |
| WO2019028976A1 (zh) | 耐热保护剂、猪瘟可室温保存活疫苗及其制备方法和应用 | |
| JP2024521329A5 (cg-RX-API-DMAC10.html) | ||
| TWI826919B (zh) | 用於長期保存的肉毒桿菌毒素冷凍乾燥製劑及其製備方法 | |
| CN120501850A (zh) | 一种用于流感减毒活疫苗的冻干保护体系 | |
| JP2022514942A (ja) | ペグアスパラガーゼの凍結乾燥組成物 | |
| EP4628092A8 (en) | Insulin aspart composition (embodiments) | |
| HK40114234A (en) | Botulinum toxin freeze-dried dosage form composition storable for long time | |
| JP2024523443A5 (cg-RX-API-DMAC10.html) | ||
| CN116164500A (zh) | 一种恒温检测酶制剂冷冻干燥的方法 | |
| US20250009855A1 (en) | Complement factor-i formulations | |
| CN117643578A (zh) | 一种甲磺酸加贝酯冻干制剂及其制备方法 | |
| WO2024050451A3 (en) | Compositions and methods for optimized covid peptide vaccines |